Find source-listed protocol references by product, formulation and route. These references support a conversation with your care team; they do not establish your eligibility or replace your prescription.
Not medical advice or individualized dosing instructions. The tables below are transcribed from the Protide Life partner portal, checked November 2, 2026. They have not been independently validated as recommended treatment regimens. Do not start, change or repeat medication based on this page.
The source describes the schedule as pharmacy-partner reference information for patient-specific compounded products. Rows marked “Dosing by Better Health” were converted by Better Health from that schedule. Every patient requires an individual evaluation, and the reviewing physician sets the actual prescription.
Your prescription and dispensing-pharmacy instructions take priority. Different concentrations can deliver different amounts of medication at the same volume or syringe marking. The tables are not universal starting-dose schedules. Ask your prescribing clinician and pharmacist to confirm your exact formulation, concentration, dose, route, device, timing and follow-up before use.
Find your product
- BPC-157
- Build Blend
- Cognitive Blend
- DSIP
- Epitalon
- GHK-CU
- Glutathione
- Kisspeptin-10
- LL-37
- Melanotan II
- MOTS-C
- NAD+
- Performance Blend
- PT-141 10mg
- Semaglutide + B12
- Sermorelin
- SS-31 (Elamipretide)
- TB-500
- Tesamorelin
- Thymosin A-1
- Tirzepatide + B12
- Wolverine Blend
- 5-Amino 50mg
- BPC-157 Capsules
- Dihexa 5mg
- Dihexa/Tesofensine 5mg/500mcg
- Ibutamoren (MK-677) 25mg
- SLU-PP 332 250mcg
- Tesofensine 500mcg
- NAD+ Nasal Spray
- Selank Nasal Spray
- Semax Nasal Spray (20mL) Starter
- Tirzepatide with glycine — no matching protocol on file
- Semaglutide with glycine — no matching protocol on file
- CJC-1295 / Ipamorelin / Sermorelin — no matching protocol on file
- Reusable injector pen — no matching protocol on file
- Ondansetron — no matching protocol on file
- SLU-PP-332 / BAM15 — no matching protocol on file
- Methylene blue capsules — no matching protocol on file
- BPC-157/TB-500 capsules — no matching protocol on file
- Tesamorelin / Ipamorelin — no matching protocol on file
- Pinealon / PE-22-28 / Selank — no matching protocol on file
- MOTS-c / Tesamorelin — no matching protocol on file
- LIPO-C — no matching protocol on file
- LIPO-B — no matching protocol on file
- Gonadorelin — no matching protocol on file
- GHK-Cu / Epithalon / CJC — no matching protocol on file
- GHK-Cu / Epithalon — no matching protocol on file
- DSIP / BPC / CJC — no matching protocol on file
- GLOW Blend — no matching protocol on file
- BPC-157 / KPV / TB-500 — no matching protocol on file
- Recovery Blend (KLOW) — no matching protocol on file
Injectables
BPC-157
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| BPC-157 | BPC-157 3mg/mL (5ML) | INJECT 0.20ML (20 UNITS) INTRAMUSCULARLY ONCE DAILY AT INJURY SITE AS DIRECTED |
Related reading: BPC-157 for Tendon Pain: What to Ask Before a Consultation · BPC-157: What the Research Shows—and What Remains Unknown
Build Blend
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Build Blend | IGF-LR3 200mcg/mL (5ML) | INJECT 0.20ML (20 UNITS) SUBCUTANEOUSLY MONDAY THROUGH FRIDAY NIGHTS AT BEDTIME |
Related reading: IGF-LR3 Is Not Ordinary IGF-1: How to Read the Evidence Carefully
Cognitive Blend
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Cognitive Blend | Selank/Semax (Focus Blend) 1mg/1mg/mL (5ML) | INJECT 0.20ML (20 UNITS) SUBCUTANEOUSLY ONCE DAILY MONDAY THROUGH FRIDAY |
Related reading: Semax and Selank Together: What “Focus and Calm” Leaves Unanswered
DSIP
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| DSIP | DSIP 1mg/mL (5ML) | INJECT 0.20ML (20 UNITS) SUBCUTANEOUSLY MONDAY THROUGH FRIDAY NIGHTS AT BEDTIME |
Related reading: DSIP for Sleep: What the Human Insomnia Studies Actually Measured
Epitalon
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Epitalon | Epithalon 2mg/mL (5ML) | INJECT 0.20ML (20 UNITS) SUBCUTANEOUSLY ONCE DAILY MONDAY THROUGH FRIDAY |
Related reading: Epithalon and Telomeres: Why a Cell Finding Is Not a Longevity Result
GHK-CU
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| GHK-CU | GHK-Cu 10mg/mL (5ML) | INJECT 0.20ML (20 UNITS) SUBCUTANEOUSLY ONCE DAILY MONDAY THROUGH FRIDAY |
Related reading: GHK-Cu for Skin: Why Topical and Injectable Evidence Must Stay Separate
Glutathione
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Glutathione | Glutathione 200mg/mL (10ML) | INJECT 0.50ML (50 UNITS) INTRAMUSCULARLY TWICE WEEKLY |
Related reading: Glutathione Injections: What Does “Detox” Actually Mean?
Kisspeptin-10
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Kisspeptin-10 | Kisspeptin 2mg/mL (5ML) | INJECT 0.05ML (5 UNITS) SUBCUTANEOUSLY TWICE WEEKLY Dosing by Better Health from the pharmacy schedule |
Related reading: Kisspeptin and Sexual Desire: What Early Human Studies Can—and Cannot—Tell You
LL-37
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| LL-37 | LL-37 1mg/mL (5ML) | INJECT 0.20ML (20 UNITS) SUBCUTANEOUSLY ONCE DAILY MONDAY THROUGH FRIDAY Dosing by Better Health from the pharmacy schedule |
Related reading: LL-37: What Human Wound Studies Mean for Broader Health Claims
Melanotan II
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Melanotan II | Melanotan II 2mg/mL (5ML) | INJECT 0.20ML (20 UNITS) SUBCUTANEOUSLY ONCE DAILY MONDAY THROUGH FRIDAY |
Related reading: Melanotan II and Tanning: Questions a Cosmetic Goal Should Not Hide
MOTS-C
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| MOTS-C | MOTS-C 2mg/mL (5ML) | INJECT 0.20ML (20 UNITS) SUBCUTANEOUSLY MONDAY THROUGH FRIDAY MORNINGS |
Related reading: MOTS-c and Exercise: Why an Exercise-Related Peptide Is Not an Exercise Replacement
NAD+
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| NAD+ | NAD+ 100mg/mL (10ML) | INJECT 0.20ML (20 UNITS) SUBCUTANEOUSLY ONCE DAILY MONDAY THROUGH FRIDAY |
Related reading: NAD+ Injections and Infusions: A Metabolism Study Is Not a Longevity Guarantee
Performance Blend
The source lists CJC-1295/Ipamorelin but does not specify DAC status. Do not assume it matches a formulation discussed in a separate article; ask your prescribing clinician and dispensing pharmacist to confirm.
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Performance Blend | CJC-1295/Ipamorelin 1.2mg/2.4mg/mL (5ML) | INJECT 0.125ML (12.5 UNITS) SUBCUTANEOUSLY ONCE DAILY Dosing by Better Health from the pharmacy schedule |
Related reading: CJC Without DAC and Ipamorelin: Why the Exact Formulation Matters
PT-141 10mg
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| PT-141 10mg | PT-141 2mg/mL (5ML) | INJECT 0.05ML-0.10ML (5-10 UNITS) SUBCUTANEOUSLY 2-4 HOURS PRIOR TO SEXUAL ACTIVITY |
Related reading: PT-141 and Bremelanotide: Matching Sexual-Desire Claims to the Evidence
Semaglutide + B12
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Semaglutide + B12 | Semaglutide + B12 Injection 10mg/0.5mg/mL (1ML) | INJECT 0.25ML (25 UNITS) SUBCUTANEOUSLY ONCE WEEKLY |
| Semaglutide + B12 | Semaglutide + B12 Injection 1mg/0.5mg/mL (1ML) | INJECT 0.25ML (25 UNITS) SUBCUTANEOUSLY ONCE WEEKLY |
| Semaglutide + B12 | Semaglutide + B12 Injection 2mg/0.5mg/mL (1ML) | INJECT 0.25ML (25 UNITS) SUBCUTANEOUSLY ONCE WEEKLY |
| Semaglutide + B12 | Semaglutide + B12 Injection 4mg/0.5mg/mL (1ML) | INJECT 0.25ML (25 UNITS) SUBCUTANEOUSLY ONCE WEEKLY |
| Semaglutide + B12 | Semaglutide + B12 Injection 6mg/0.5mg/mL (1ML) | INJECT 0.25ML (25 UNITS) SUBCUTANEOUSLY ONCE WEEKLY |
Related reading: Semaglutide With B12: What Does the Added Vitamin Actually Establish?
Sermorelin
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Sermorelin | Sermorelin 3mg/mL (5ML) | INJECT 0.20ML (20 UNITS) SUBCUTANEOUSLY MONDAY THROUGH FRIDAY NIGHTS |
Related reading: Sermorelin and Growth Hormone: Setting Useful Expectations for a Consultation
SS-31 (Elamipretide)
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| SS-31 (Elamipretide) | SS-31 2mg/mL (5ML) | INJECT 0.20ML (20 UNITS) SUBCUTANEOUSLY MONDAY THROUGH FRIDAY MORNINGS |
Related reading: SS-31 and Elamipretide: Why a Rare-Disease Trial Is Not a Wellness Forecast
TB-500
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| TB-500 | TB-500 3mg/mL (5ML) | INJECT 0.20ML (20 UNITS) SUBCUTANEOUSLY MONDAY THROUGH FRIDAY MORNINGS |
Related reading: TB-500 and Thymosin Beta-4: Why the Name on the Study Matters
Tesamorelin
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Tesamorelin | Tesamorelin 2mg/mL (10ML) | INJECT 0.30ML (30 UNITS) SUBCUTANEOUSLY MONDAY THROUGH FRIDAY NIGHTS AT BEDTIME Dosing by Better Health from the pharmacy schedule |
Related reading: Tesamorelin and Visceral Fat: Why the Trial Population Matters
Thymosin A-1
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Thymosin A-1 | Thymosin Alpha-1 2mg/mL (5ML) | INJECT 0.25ML (25 UNITS) SUBCUTANEOUSLY TWICE WEEKLY Dosing by Better Health from the pharmacy schedule |
Related reading: Thymosin Alpha-1: Why “Immune Support” Needs a Clinical Definition
Tirzepatide + B12
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Tirzepatide + B12 | Tirzepatide + B12 10mg/mL (2ML) | INJECT 0.50ML (50 UNITS) SUBCUTANEOUSLY ONCE WEEKLY |
| Tirzepatide + B12 | Tirzepatide + B12 15mg/mL (2ML) | INJECT 0.50ML (50 UNITS) SUBCUTANEOUSLY ONCE WEEKLY |
| Tirzepatide + B12 | Tirzepatide + B12 20mg/mL (2ML) | INJECT 0.50ML (50 UNITS) SUBCUTANEOUSLY ONCE WEEKLY |
| Tirzepatide + B12 | Tirzepatide + B12 25mg/mL (2ML) | INJECT 0.50ML (50 UNITS) SUBCUTANEOUSLY ONCE WEEKLY |
| Tirzepatide + B12 | Tirzepatide + B12 30mg/mL (2ML) | INJECT 0.50ML (50 UNITS) SUBCUTANEOUSLY ONCE WEEKLY |
| Tirzepatide + B12 | Tirzepatide + B12 5mg/mL (2ML) | INJECT 0.50ML (50 UNITS) SUBCUTANEOUSLY ONCE WEEKLY |
Related reading: Tirzepatide With B12: Reading Weight-Loss and Energy Claims Separately
Wolverine Blend
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Wolverine Blend | BPC-157/TB500 3mg/3mg/mL (5ML) | INJECT 0.20ML (20 UNITS) SUBCUTANEOUSLY MONDAY THROUGH FRIDAY MORNINGS AT SITE OF INJURY |
Related reading: BPC-157 and TB-500: Looking Beyond the “Wolverine Blend” Nickname
Capsules and tablets
5-Amino 50mg
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| 5-Amino 50mg | 5-Amino capsules 50mg (30 CT) | TAKE 1 CAPSULE BY MOUTH ONCE DAILY IN THE MORNING |
Related reading: “5-Amino” Capsules: Confirm the Ingredient Before Reading NNMT Claims
BPC-157 Capsules
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| BPC-157 Capsules | BPC-157 capsules 500mcg (30 CT) | TAKE 1 CAPSULE BY MOUTH EVERY MORNING **WITH WATER ONLY** |
Related reading: BPC-157 Capsules: Does Changing the Route Change the Evidence?
Dihexa 5mg
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Dihexa 5mg | Dihexa capsules 5mg (30 CT) | TAKE 1 CAPSULE BY MOUTH ONCE DAILY |
Related reading: Dihexa and Memory: What Preclinical Research Does Not Establish for Capsules
Dihexa/Tesofensine 5mg/500mcg
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Dihexa/Tesofensine 5mg/500mcg | Dihexa/Tesofensine capsules 5mg/500mcg (30 CT) | TAKE 1 CAPSULE BY MOUTH ONCE DAILY |
Related reading: Dihexa and Tesofensine: Why Cognition and Weight-Loss Claims Do Not Validate a Blend
Ibutamoren (MK-677) 25mg
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Ibutamoren (MK-677) 25mg | Ibutamoren (MK-677) capsules 25mg (30 CT) | TAKE 1-2 CAPSULE BY MOUTH ONCE DAILY IN THE MORNING |
Related reading: Ibutamoren (MK-677): More Lean Mass Is Not the Same as More Strength
SLU-PP 332 250mcg
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| SLU-PP 332 250mcg | SLU_PP 332 capsules 250mcg (30 CT) | TAKE 1 CAPSULE BY MOUTH ONCE DAILY IN THE MORNING |
Related reading: SLU-PP-332: What “Exercise Mimetic” Means in Mouse Research
Tesofensine 500mcg
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Tesofensine 500mcg | Tesofensine capsules 500mcg (30 CT) | TAKE 1 CAPSULE BY MOUTH ONCE DAILY IN THE MORNING |
Related reading: Tesofensine for Weight Loss: Read the Trial—and the Publication Notice
Nasal sprays
NAD+ Nasal Spray
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| NAD+ Nasal Spray | NAD+ Nasal Spray 300mg/mL (25mL) | ONE SPRAY IN EACH NOSTRIL TWICE DAILY |
Related reading: NAD+ Nasal Spray: Does a Nasal Route Prove Brain or Energy Benefits?
Selank Nasal Spray
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Selank Nasal Spray | Selank Nasal Spray 2.5mg/mL (20mL) | ONE SPRAY IN EACH NOSTRIL TWICE DAILY |
Related reading: Selank Nasal Spray and Anxiety: How to Read the Small Clinical Studies
Semax Nasal Spray (20mL) Starter
This source entry is specifically labeled 20mL Starter. Instructions for a different concentration or spray device must be confirmed separately.
| Product | Pharmacy pack | Source-listed pharmacy instructions — not a prescription |
|---|---|---|
| Semax Nasal Spray (20mL) Starter | Semax Nasal Spray 2.5mg/mL (20mL) | ONE SPRAY IN EACH NOSTRIL TWICE DAILY |
Related reading: Semax Nasal Spray: Why Stroke Research Does Not Prove Everyday Focus Benefits
Products and formulations without a matching protocol
Tirzepatide with glycine
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: Tirzepatide With Glycine: Ask About the Formulation and the Longer-Term Plan
Semaglutide with glycine
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: Semaglutide With Glycine: Formulation, Concentration, and the Questions to Ask
CJC-1295 / Ipamorelin / Sermorelin
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: CJC-1295, Ipamorelin, and Sermorelin: Does a Triple Blend Have Triple Evidence?
Reusable injector pen
The source does not provide pen dosing. A device has no universal medication dose: use only the instructions for the exact prescribed cartridge and compatible device. Do not convert vial instructions to pen clicks.
Related reading: Reusable Injection Pens: Verify the Device, Cartridge, and Instructions Together
Ondansetron
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: Ondansetron and Nausea: Relief Should Not Replace Finding the Cause
SLU-PP-332 / BAM15
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: SLU-PP-332 With BAM15: Why Two Experimental Mechanisms Do Not Make a Proven Capsule
Methylene blue capsules
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: Methylene Blue Capsules: Memory Research and Medication Interactions Belong Together
BPC-157/TB-500 capsules
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: BPC-157/TB-500 Capsules: Two Evidence Gaps to Check Before the Blend Claim
Tesamorelin / Ipamorelin
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: Tesamorelin With Ipamorelin: Two Ingredients, Separate Evidence Questions
Pinealon / PE-22-28 / Selank
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: Pinealon, PE-22-28, and Selank: Reading a Cognitive Blend Claim by Claim
MOTS-c / Tesamorelin
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: MOTS-c and Tesamorelin: Why Metabolic Research Does Not Validate a Blend
LIPO-C
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: LIPO-C and “Fat Metabolism”: What That Phrase Leaves Unanswered
LIPO-B
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: LIPO-B Injections: Separating Vitamin Support From Weight-Loss Promises
Gonadorelin
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: Gonadorelin and Fertility: Why Pulsatile Delivery Changes the Question
GHK-Cu / Epithalon / CJC
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: GHK-Cu, Epithalon, and CJC: How to Read Three-Pathway Wellness Claims
GHK-Cu / Epithalon
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: GHK-Cu and Epithalon: Two Research Stories, One Unanswered Blend Question
DSIP / BPC / CJC
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: DSIP, BPC, and CJC: Can a Sleep Blend Be Judged by Its Ingredients?
GLOW Blend
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: The GLOW Blend: Skin Claims, Recovery Claims, and the Evidence Between Them
BPC-157 / KPV / TB-500
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: BPC-157, KPV, and TB-500: A Patient’s Guide to Evaluating the Blend
Recovery Blend (KLOW)
No matching protocol for this exact product or formulation was available in the source page when checked. A dose for an individual ingredient, another blend or a different route must not be substituted. Ask your prescribing clinician or dispensing pharmacy for the instructions for your prescription.
Related reading: The KLOW Blend: How to Evaluate Four Ingredients Without Assuming Four Benefits
Source limitations and individual care
The source omits dry powders and pen cartridges. It states that dry-powder volumes depend on reconstitution and that pen dosing requires separate pharmacy instructions. No doses have been inferred for missing products or carried across formulations.
Source attribution: dosing compiled by the pharmacy partner for ProtideLife, and by Better Health where marked. Independent provider judgment supersedes the reference schedule. Product availability and pharmacy instructions may change.
Compounded drugs are not FDA-approved; FDA does not review their safety, effectiveness or quality before marketing. See the FDA’s compounding questions and answers.
